Pfizer to supply medicines worth $70 million in India
Pfizer is going to supply medicines worth $70 million in India. The company said it is in talks with the Centre to allow the use of its Covid vaccine in India. Covishield and covaxin are being supplied in the country. Sputnik V will also be availble in the future.